FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccine | pneumonia

Researchers: Pneumonia vax cuts heart disease risk

A new study indicates that a pneumonia vaccine can significantly cut the risk of heart disease. The study, published in the Canadian Medical Association Journal, concluded that the vaccine reduced the risk of heart attacks in the elderly by as much as 50 percent.

"The magnitude of the effect was really surprising for us," said Dr. Danielle Pilon, the study's lead author and an associate professor of medicine at the Universite de Sherbrooke in Quebec. "We didn't expect the vaccine to lower the risk of heart attacks by such a high rate."

Researchers believe that the vaccine has anti-inflammatory properties, which inhibits the buildup of plaque in blood vessels. And they're urging physicians to use the pneumonia vaccine more liberally as a protection against heart attacks.

- read the report from Canada.com

Related Article:
Key target found for new pneumonia vaccine


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Vaccine   pneumonia  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.